Abstract:
The present invention relates to methods for enriching pluripotent stem cell-derived cardiomyocyte progenitor cells and cardiomyocyte cells based on SIRPA expression.
Abstract:
The present invention relates to methods for enriching pluripotent stem cell-derived cardiomyocyte progenitor cells and cardiomyocyte cells based on SIRPA expression.
Abstract:
The present invention relates to methods for enriching pluripotent stem cell-derived cardiomyocyte progenitor cells and cardiomyocyte cells based on SIRPA expression.
Abstract:
The present invention relates to methods for enriching pluripotent stem cell-derived cardiomyocyte progenitor cells and cardiomyocyte cells based on SIRPA expression.
Abstract:
The present invention relates to methods for enriching pluripotent stem cell-derived cardiomyocyte progenitor cells and cardiomyocyte cells based on SIRPA expression.
Abstract:
The present invention relates to methods for enriching pluripotent stem cell-derived cardiomyocyte progenitor cells and cardiomyocyte cells based on SIRPA expression.
Abstract:
The present invention relates to methods for enriching pluripotent stem cell-derived cardiomyocyte progenitor cells and cardiomyocyte cells based on SIRPA expression.
Abstract:
Un método de enriquecimiento de una población de células para células cardiomiocitos y células progenitoras de cardiomiocitos, que comprende: (a) proporcionar la población de células de la que tiene que aislarse las células cardiomiocitos y las células progenitoras de cardiomiocitos; y (b) obtener una población enriquecida de cardiomiocitos y células progenitoras de cardiomiocitos basándose en la expresión de SIRPA aislando células que expresan SIRPA de la población; en el que la población de células comprende una población de células madre pluripotentes humanas inducidas para diferenciase en células cardiomiocitos y células progenitoras de cardiomiocitos.